Pernille Bejer Nordentoft1,2, Thomas Engell-Sørensen1,2, Sanne Jespersen1,2, Faustino Gomes Correia3, Candida Medina3, David da Silva Té3, Lars Østergaard2, Alex Lund Laursen2, Christian Wejse4,5,6, Bo Langhoff Hønge1,2,7. 1. Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau. 2. Department of Infectious Diseases, Aarhus University Hospital, 8200, Aarhus N, Denmark. 3. National HIV Programme, Ministry of Health, Bissau, Guinea-Bissau. 4. Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau. wejse@dadlnet.dk. 5. Department of Infectious Diseases, Aarhus University Hospital, 8200, Aarhus N, Denmark. wejse@dadlnet.dk. 6. GloHAU, Center for Global Health, School of Public Health, Aarhus University, 8000, Aarhus C, Denmark. wejse@dadlnet.dk. 7. Department of Clinical Immunology, Aarhus University Hospital, 8200, Aarhus N, Denmark.
Abstract
PURPOSE: The objective of this study was to ascertain vital status of patients considered lost to follow-up at an HIV clinic in Guinea-Bissau, and describe reasons for loss to follow-up (LTFU). METHODS: This study was a cross-sectional sample of a prospective cohort, carried out between May 15, 2013, and January 31, 2014. Patients lost to follow-up, who lived within the area of the Bandim Health Project, a demographic surveillance site (DSS), were eligible for inclusion. Active follow-up was attempted by telephone and tracing by a field assistant. Semi-structured interviews were done face to face or by phone by a field assistant and patients were asked why they had not shown up for the scheduled appointment. Patients were included by date of HIV testing and risk factors for LTFU were assessed using Cox proportional hazard model. RESULTS: Among 561 patients (69.5 % HIV-1, 18.0 % HIV-2 and 12.6 % HIV-1/2) living within the DSS, 292 patients had been lost to follow-up and were, therefore, eligible for active follow-up. Vital status was ascertained in 65.9 % of eligible patients and 42.7 % were alive, while 23.2 % had died. Information on reasons for LTFU existed for 103 patients. Major reasons were moving (29.1 %), travelling (17.5 %), and transferring to other clinics (11.7 %). CONCLUSION: A large proportion of the patients at the clinic were lost to follow-up. The main reason for this was found to be the geographic mobility of the population in Guinea-Bissau.
PURPOSE: The objective of this study was to ascertain vital status of patients considered lost to follow-up at an HIV clinic in Guinea-Bissau, and describe reasons for loss to follow-up (LTFU). METHODS: This study was a cross-sectional sample of a prospective cohort, carried out between May 15, 2013, and January 31, 2014. Patients lost to follow-up, who lived within the area of the Bandim Health Project, a demographic surveillance site (DSS), were eligible for inclusion. Active follow-up was attempted by telephone and tracing by a field assistant. Semi-structured interviews were done face to face or by phone by a field assistant and patients were asked why they had not shown up for the scheduled appointment. Patients were included by date of HIV testing and risk factors for LTFU were assessed using Cox proportional hazard model. RESULTS: Among 561 patients (69.5 % HIV-1, 18.0 % HIV-2 and 12.6 % HIV-1/2) living within the DSS, 292 patients had been lost to follow-up and were, therefore, eligible for active follow-up. Vital status was ascertained in 65.9 % of eligible patients and 42.7 % were alive, while 23.2 % had died. Information on reasons for LTFU existed for 103 patients. Major reasons were moving (29.1 %), travelling (17.5 %), and transferring to other clinics (11.7 %). CONCLUSION: A large proportion of the patients at the clinic were lost to follow-up. The main reason for this was found to be the geographic mobility of the population in Guinea-Bissau.
Entities:
Keywords:
Guinea-Bissau; HIV; Loss to follow-up; Mortality; Retention; West Africa
Authors: Kimberly B Ulett; James H Willig; Hui-Yi Lin; Justin S Routman; Sarah Abroms; Jeroan Allison; Ashlee Chatham; James L Raper; Michael S Saag; Michael J Mugavero Journal: AIDS Patient Care STDS Date: 2009-01 Impact factor: 5.078
Authors: María Martínez Colubi; María Jesús Pérez-Elías; Laura Elías; María Pumares; Alfonso Muriel; Ana Moreno Zamora; Jose Luis Casado; Fernando Dronda; Dolores López; Santiago Moreno Journal: HIV Clin Trials Date: 2012 Sep-Oct
Authors: Mona R Loutfy; Wei Wu; Michelle Letchumanan; Lise Bondy; Tony Antoniou; Shari Margolese; Yimeng Zhang; Sergio Rueda; Frank McGee; Ryan Peck; Louise Binder; Patricia Allard; Sean B Rourke; Paula A Rochon Journal: PLoS One Date: 2013-02-13 Impact factor: 3.240
Authors: Kara G Marson; Kenneth Tapia; Pamela Kohler; Christine J McGrath; Grace C John-Stewart; Barbra A Richardson; Julia W Njoroge; James N Kiarie; Samah R Sakr; Michael H Chung Journal: PLoS One Date: 2013-10-24 Impact factor: 3.240
Authors: Inés Oliveira; Andreas Andersen; Alcino Furtado; Candida Medina; David da Silva; Zacarias J da Silva; Peter Aaby; Alex Lund Laursen; Christian Wejse; Jesper Eugen-Olsen Journal: BMJ Open Date: 2012-11-14 Impact factor: 2.692
Authors: Norma C Ware; Monique A Wyatt; Elvin H Geng; Sylvia F Kaaya; Oche O Agbaji; Winnie R Muyindike; Guerino Chalamilla; Patricia A Agaba Journal: PLoS Med Date: 2013-01-08 Impact factor: 11.069
Authors: Thomas Engell-Sørensen; Andreas Rieckmann; Candida Medina; David da Silva Té; Amabelia Rodrigues; Ane Bærent Fisker; Peter Aaby; Christian Erikstrup; Sanne Jespersen; Christian Wejse; Bo Langhoff Hønge Journal: Infection Date: 2021-02-02 Impact factor: 3.553
Authors: Jinzhao Xie; Jing Gu; Xiuyuan Chen; Cong Liu; Haidan Zhong; Peishan Du; Quanmin Li; Joseph T F Lau; Chun Hao; Linghua Li; Yuantao Hao; Weiping Cai Journal: AIDS Behav Date: 2021-10-26
Authors: Joakim Esbjörnsson; Marianne Jansson; Sanne Jespersen; Fredrik Månsson; Bo L Hønge; Jacob Lindman; Candida Medina; Zacarias J da Silva; Hans Norrgren; Patrik Medstrand; Sarah L Rowland-Jones; Christian Wejse Journal: AIDS Res Ther Date: 2019-09-05 Impact factor: 2.250
Authors: Steven Y Hong; Anna Winston; Nicholus Mutenda; Ndapewa Hamunime; Tuhin Roy; Christine Wanke; Alice M Tang; Michael R Jordan Journal: PLoS One Date: 2022-04-14 Impact factor: 3.240
Authors: S Jespersen; F Månsson; J Lindman; C Wejse; C Medina; Z J da Silva; DdS Te; P Medstrand; J Esbjörnsson; B L Hønge Journal: AIDS Res Ther Date: 2020-02-04 Impact factor: 2.250
Authors: Noelle A Benzekri; Jacques F Sambou; Sanou Ndong; Mouhamadou Baïla Diallo; Ibrahima Tito Tamba; Dominique Faye; Jean Philippe Diatta; Khadim Faye; Ibrahima Sall; Fatima Sall; Ousseynou Cisse; Jean Jacques Malomar; Cheikh T Ndour; Papa Salif Sow; Stephen E Hawes; Moussa Seydi; Geoffrey S Gottlieb Journal: AIDS Care Date: 2021-03-08